Pharma Mar SA
MAD:PHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharma Mar SA
MAD:PHM
|
ES |
|
Infotel SA
PAR:INF
|
FR |
|
HF Company SA
PAR:ALHF
|
FR |
|
Vertiv Holdings Co
NYSE:VRT
|
US |
|
T
|
Tai United Holdings Ltd
HKEX:718
|
HK |
|
ChZPSN-Profnastil PAO
MOEX:PRFN
|
RU |
|
F
|
Fabled Copper Corp
CNSX:FABL
|
CA |
|
H
|
Heidelberg Materials AG
F:HEIU
|
DE |
|
National Cinemedia Inc
NASDAQ:NCMI
|
US |
|
B
|
Banco Patagonia SA
BCBA:BPAT
|
AR |
|
B
|
Bonvests Holdings Ltd
SGX:B28
|
SG |
|
I
|
Imperial Ginseng Products Ltd
XTSX:IGP
|
CA |
Wall St Price Targets
PHM Price Targets Summary
Pharma Mar SA
According to Wall Street analysts, the average 1-year price target for PHM is 102.12 EUR with a low forecast of 63.29 EUR and a high forecast of 131.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHM's stock price target?
Price Target
102.12
EUR
According to Wall Street analysts, the average 1-year price target for PHM is 102.12 EUR with a low forecast of 63.29 EUR and a high forecast of 131.25 EUR.
What is the Revenue forecast for Pharma Mar SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Pharma Mar SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 17%.
What is the Operating Income forecast for Pharma Mar SA?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 27%.
What is the Pre-Tax Income forecast for Pharma Mar SA?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 48%.
What is the Net Income forecast for Pharma Mar SA?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 8 years is 19%.
